M&A Deal Summary

LGM Pharma Acquires Nexgen Pharma

On July 27, 2020, LGM Pharma acquired life science company Nexgen Pharma

Acquisition Highlights
  • This is LGM Pharma’s 1st transaction in the Life Science sector.
  • This is LGM Pharma’s 1st transaction in the United States.
  • This is LGM Pharma’s 1st transaction in California.

M&A Deal Summary

Date 2020-07-27
Target Nexgen Pharma
Sector Life Science
Buyer(s) LGM Pharma
Deal Type Add-on Acquisition
Advisor(s) BlackArch (Financial)
Stradling Yocca Carlson & Rauth (Legal)

Target

Nexgen Pharma

Irvine,, California, United States
Formed in 1925, Nexgen Pharma specializes in the development and manufacture of solid dose, powder and liquid Rx drugs, Medical Foods, OTC drugs, and dietary supplements. It has three facilities located in Irvine, California; Rosenberg, Texas, and Colorado Springs, Colorado which total more than 350,000 square feet of manufacturing, product development, laboratory and warehouse/distribution space.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

LGM Pharma

Boca Raton, Florida, United States

Category Company
Founded 2005
Sector Life Science
DESCRIPTION

LGM Pharma specializes in streamlining the API supply chain throughout all development stages while providing complete technical capabilities and expert regulatory support for a wide range of products. LGM Pharma was founded in 2005 and is based in Boca Raton, Florida.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1